Eila C Skinner
Overview
Explore the profile of Eila C Skinner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
1971
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chowdhury D, Apolo A, Jiang D, Skinner E, Chisolm S, Bangs R, et al.
BJU Int
. 2025 Mar;
PMID: 40047292
Objectives: To evaluate the impact of advocacy efforts by organisations such as the Bladder Cancer Advocacy Network (BCAN) to increase awareness about the signs, symptoms, diagnosis, treatment and need for...
2.
Del Giudice F, Vestri A, Fegatelli D, Husch T, Belsey J, Nair R, et al.
BJU Int
. 2024 Oct;
135(2):346-354.
PMID: 39397266
Background: A second transurethral resection of bladder tumour (Re-TURBT) is recommended by European Association of Urology (EAU) Guidelines on non-muscle-invasive bladder cancers (NMIBCs) due to the risk of understaging and/or...
3.
Soerensen S, Schmidt B, Thomas I, Montez-Rath M, Thong A, Prado K, et al.
J Urol
. 2024 Oct;
213(1):52-59.
PMID: 39357009
Purpose: Patients treated with radical cystectomy experience a high rate of postoperative complications and frequent hospital readmissions. We sought to explore the utility of the Care Assessment Need (CAN) score,...
4.
5.
6.
7.
Schmidt B, Velaer K, Thomas I, Ganesan C, Song S, Pao A, et al.
Eur Urol Open Sci
. 2022 Jan;
35:29-36.
PMID: 35024629
Background: Patients with chronic kidney disease (CKD) are poor candidates for standard treatments for muscle-invasive bladder cancer (MIBC) and may be more likely to experience adverse outcomes when diagnosed with...
8.
Shkolyar E, Zhao Q, Mach K, Teslovich N, Lee T, Cox S, et al.
Urol Oncol
. 2021 Mar;
39(8):497.e9-497.e15.
PMID: 33766467
Objectives: The risk of bladder cancer (BCa) diagnosis and recurrence necessitates cystoscopy. Improved risk stratification may inform personalized triage and surveillance strategies. We aim to develop a urinary mRNA biomarker...
9.
Del Giudice F, Busetto G, Gross M, Maggi M, Sciarra A, Salciccia S, et al.
J Cancer Res Clin Oncol
. 2021 Mar;
147(10):3073-3080.
PMID: 33675400
Purpose: (I) To evaluate the clinical efficacy of three different BCG strains in patients with intermediate-/high-risk non-muscle-invasive bladder cancer (NMIBC). (II) To determine the importance of performing routine secondary resection...
10.
Huen K, Lee C, Skinner E, Terris M, Kobashi K, Bennett C, et al.
Urology
. 2020 Oct;
150:81-85.
PMID: 33080254
No abstract available.